Profound Medical is a leading brand that specializes in customizable incision-free therapies for various medical conditions. Their innovative technology, including the TULSA-PRO® and Sonalleve® systems, provides patients with effective and precise treatment options. One of their flagship products is the TULSA-PRO® system, which uses transurethral ultrasound ablation to treat prostate diseases without the need for incisions.

This patient-centric solution is robotically controlled by physicians, ensuring accurate and targeted treatment delivery. With real-time MRI imaging, TULSA-PRO® prioritizes patient well-being while achieving precise and accurate treatment outcomes. The TULSA Procedure, offered by Profound Medical, allows for customizable treatment planning and 360-degree targeting capability.

This flexibility enables physicians to treat a wide range of conditions, including localized prostate cancer, prostate cancer combined with obstructive BPH, localized radiorecurrent prostate cancer, and large volume BPH. With a focus on patient safety, the TULSA Procedure utilizes MRI guidance, real-time monitoring, and precise control to minimize complications. The procedure has demonstrated durable efficacy and safety, supported by 20+ clinical publications with up to 5-year outcomes.

Profound Medical aims to empower physicians and patients through their comprehensive data and educational platform. By providing in-depth knowledge and insights, they strive to improve patient outcomes and advance the field of medical technology. For more information about Profound Medical and their groundbreaking therapies, visit their website or follow them on Facebook, Twitter, LinkedIn, and YouTube